PAVmed Inc.
For the period ended Dec 31, 2025. Filed Mar 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 27, 2026
PAVM$1.63+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
The information required by this Item 11 is incorporated by reference to our Proxy Statement for the2026 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within120 days of the fiscal year ended* December 31, 2025*.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.